benphothiamine and uridine diphosphate n-acetylglucosamine

benphothiamine has been researched along with uridine diphosphate n-acetylglucosamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergfeld, R; Bierhaus, A; Brownlee, M; Du, X; Edelstein, D; Giardino, I; Hammes, HP; Hannak, D; Ju, Q; Lin, J; Matsumura, T; Nawroth, P; Neumaier, M; Taguchi, T	1

Other Studies

1 other study(ies) available for benphothiamine and uridine diphosphate n-acetylglucosamine

Article	Year
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature medicine, 2003, Volume: 9, Issue:3 Topics: Animals; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Enzyme Activation; Glucose; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; NF-kappa B; Protein Kinase C; Random Allocation; Rats; Rats, Wistar; Retina; Thiamine; Transketolase; Uridine Diphosphate N-Acetylglucosamine	2003

Article

Year

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Nature medicine, 2003, Volume: 9, Issue:3

Topics: Animals; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Enzyme Activation; Glucose; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; NF-kappa B; Protein Kinase C; Random Allocation; Rats; Rats, Wistar; Retina; Thiamine; Transketolase; Uridine Diphosphate N-Acetylglucosamine

2003